Recommendations for transfusion in ABO-incompatible hematopoietic stem cell transplantation.
作者信息
O'Donghaile Diarmaid, Kelley Walter, Klein Harvey G, Flegel Willy A
出版信息
Transfusion. 2012 Feb;52(2):456-8. doi: 10.1111/j.1537-2995.2011.03465.x.
Abstract
摘要
相似文献
1
Recommendations for transfusion in ABO-incompatible hematopoietic stem cell transplantation.
Transfusion. 2012 Feb;52(2):456-8. doi: 10.1111/j.1537-2995.2011.03465.x.
2
Results of two protocols for platelet transfusion in patients undergoing abo incompatible hematopoietic stem cell transplantation.
Transfus Apher Sci. 2019 Apr;58(2):185-186. doi: 10.1016/j.transci.2019.02.002. Epub 2019 Mar 19.
3
Clinical guide to ABO-incompatible allogeneic stem cell transplantation.
Biol Blood Marrow Transplant. 2013 Aug;19(8):1152-8. doi: 10.1016/j.bbmt.2013.03.018. Epub 2013 Apr 6.
4
Outcome of major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation may be influenced by conditioning regimen.
Blood. 2002 Jun 15;99(12):4642-3; author reply 4643-4. doi: 10.1182/blood.v99.12.4642.
5
Analysis of donor and recipient ABO incompatibility and antibody-associated complications after allogeneic stem cell transplantation with reduced-intensity conditioning.
Biol Blood Marrow Transplant. 2014 Feb;20(2):264-71. doi: 10.1016/j.bbmt.2013.11.011. Epub 2013 Nov 22.
6
[Peripheral blood stem cell collection from ABO incompatible allogeneic donors and its effect in hematopoietic stem cell transplantation].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Oct;19(5):1237-40.
7
Transfusion support issues in hematopoietic stem cell transplantation.
Cancer Control. 2015 Jan;22(1):52-9. doi: 10.1177/107327481502200108.
8
What is the optimal approach to major ABO-incompatible allogeneic stem cell transplantation?
Biol Blood Marrow Transplant. 2013 Dec;19(12):1760. doi: 10.1016/j.bbmt.2013.09.019. Epub 2013 Oct 8.
9
Micro gel column technique is fit for detecting mixed fields post ABO incompatible hematopoietic stem cell transplantation.
Transfus Apher Sci. 2015 Apr;52(2):222-5. doi: 10.1016/j.transci.2014.12.023. Epub 2014 Dec 22.
10
Response to "What is the optimal approach to major ABO-incompatible allogeneic stem cell transplantation".
Biol Blood Marrow Transplant. 2013 Dec;19(12):1760-1. doi: 10.1016/j.bbmt.2013.10.005. Epub 2013 Oct 12.
引用本文的文献
1
Immuno-Hematologic Complexity of ABO-Incompatible Allogeneic HSC Transplantation.
Cells. 2024 May 10;13(10):814. doi: 10.3390/cells13100814.
2
TSR: A User-Friendly R Shiny Application for Assessment of Optimal Blood Product Selection in ABO-Incompatible Hematopoietic Stem Cell Transplantation.
Curr Med Sci. 2023 Aug;43(4):716-722. doi: 10.1007/s11596-023-2754-1. Epub 2023 Jun 5.
3
Pre-transplant donor-type red cell transfusion is a safe and effective strategy to reduce isohemagglutinin titers and prevent donor marrow infusion reactions in major ABO-mismatched transplants.
Ann Hematol. 2021 Aug;100(8):2071-2078. doi: 10.1007/s00277-021-04571-3. Epub 2021 Jun 19.
4
Anaesthetic implications and transfusion practices in ABO incompatible living donor liver transplantation: Case series.
Indian J Anaesth. 2021 Apr;65(4):331-335. doi: 10.4103/ija.IJA_1295_20. Epub 2021 Apr 15.
5
How we evaluate red blood cell compatibility and transfusion support for patients with sickle cell disease undergoing hematopoietic progenitor cell transplantation.
Transfusion. 2018 Nov;58(11):2483-2489. doi: 10.1111/trf.14871. Epub 2018 Sep 28.
6
Transfusion support for matched sibling allogeneic hematopoietic stem cell transplantation (1993-2010): factors that predict intensity and time to transfusion independence.
Transfusion. 2019 Jan;59(1):303-315. doi: 10.1111/trf.14966. Epub 2018 Oct 26.
7
[When A is not A anymore: problems and pitfalls with blood group typing].
Anaesthesist. 2018 Sep;67(9):637-646. doi: 10.1007/s00101-018-0483-9.
8
Transfusion Support for ABO-Incompatible Progenitor Cell Transplantation.
Transfus Med Hemother. 2016 Jan;43(1):13-8. doi: 10.1159/000441612. Epub 2015 Oct 29.
9
Pathogenesis and mechanisms of antibody-mediated hemolysis.
Transfusion. 2015 Jul;55 Suppl 2(0):S47-58. doi: 10.1111/trf.13147.
10
Molecular immunohaematology round table discussions at the AABB Annual Meeting, Denver 2013.
Blood Transfus. 2015 Jul;13(3):514-20. doi: 10.2450/2014.0213-14. Epub 2014 Dec 2.
本文引用的文献
1
How do I approach ABO-incompatible hematopoietic progenitor cell transplantation?
Transfusion. 2011 Jun;51(6):1143-9. doi: 10.1111/j.1537-2995.2011.03069.x. Epub 2011 Mar 7.
2
A practical strategy to reduce the risk of passive hemolysis by screening plateletpheresis donors for high-titer ABO antibodies.
Transfusion. 2011 Jan;51(1):92-6. doi: 10.1111/j.1537-2995.2010.02759.x.
3
Transfusion efficacy of ABO major-mismatched platelets (PLTs) in children is inferior to that of ABO-identical PLTs.
Transfusion. 2009 Jan;49(1):21-33. doi: 10.1111/j.1537-2995.2008.01914.x. Epub 2008 Sep 4.
4
Determinants of ABH expression on human blood platelets.
Blood. 2005 Apr 15;105(8):3356-64. doi: 10.1182/blood-2004-08-3080. Epub 2004 Dec 21.
5
ABO blood group antigens on human plasma von Willebrand factor after ABO-mismatched bone marrow transplantation.
Blood. 1999 Oct 15;94(8):2895-900.
Zotero 插件